US 9919056
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
granted A61KA61K2039/505A61K31/551
Quick answer
US patent 9919056 (Pyrrolobenzodiazepine-anti-CD22 antibody conjugates) held by ADC THERAPEUTICS SA expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ADC THERAPEUTICS SA
- Grant date
- Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K31/551, A61K31/5517, A61K39/001113